Cystoid macular oedema has been uncommonly reported (≥ 1/ 1000 to < 1/ 100) following treatment with LUMIGAN and should therefore be used with caution in patients with known risk factors for macular oedema (e. g. aphakic patients, pseudophakic patients with a torn posterior lens capsule).